Filter by patients with: All

What is Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)?

Category: Prescription Drugs

Most popular types: Trizivir

false

See also: Abacavir (ABC) Lamivudine (3TC) Zidovudine (ZDV)

Abacavir-Lamivudine-Zidovudine is the combination of three nucleoside reverse transcriptase inhibitor (NRTI) drugs, intended for the treatment of HIV. NRTIs block reverse transcriptase, a protein that HIV needs to make more copies of itself.

See patients taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 101 14
General health 1 0
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 118 patients that have taken Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 3
Mild 4
None 3

Commonly reported side effects and conditions associated with Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Side effect Patients Percentage
Abdominal pain 1
Anemia 1
Chronic diarrhea 1
Diarrhea 1
Fatigue 1
Lipodystrophy (lipoatrophy or loss of fatty tissue) 1

Show all 8 reported side effects

Why patients stopped taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 9
Did not seem to work 5
Other 4
Side effects too severe 3
Expense 2
Personal research 2
Course of treatment ended 1
See all 20 patients who've stopped taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Duration

Stopped taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 3
2 - 5 years 2
5 - 10 years 9
10 years or more 2
Adherence
Adherence Evaluations Percentage
Always 10
Usually 3
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 1
A little hard to take 5
Not at all hard to take 7
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 3
$25-49 1
< $25 4
Not specified 6

What people switch to and from

Patients started taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) after stopping:

Treatment Patients Percentage
Abacavir-lamivudine (ABC/3TC) (Epzicom) 1
Darunavir (DRV) (Prezista) 1
Raltegravir (RAL) (Isentress) 1
Ritonavir (RTV, /r) (Norvir) 1

Patients stopped taking Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) and switched to:

Treatment Patients Percentage
Triumeq 2
Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide (Genvoya) 1
Last updated:

5 patient evaluations for Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)

Sort by: Most recent

Feb 29, 2012 (Started Jan 10, 2006)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (lipodystrophy (lipoatrophy or loss of fatty tissue))
  • Adherence
    Always
  • Burden
    Not at all hard to take
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $25-49 monthly
  • 0 helpful marks

Dec 5, 2011 (Started Dec 03, 2003)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Mild (nausea)
  • Adherence
    Usually
  • Burden
    Not at all hard to take
Dosage: 2 x 300 mg-150 mg-300 mg Daily
Side effects: nausea

Aug 29, 2010 (Started Dec 03, 2003)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild (nausea)
  • Adherence
    Usually
  • Burden
    Not at all hard to take
Dosage: 2 x 300 mg-150 mg-300 mg Daily
Side effects: nausea
  • 0 helpful marks

Nov 2, 2011 (Started Jun 10, 2001)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 2 x 300 mg-150 mg-300 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: fatigue

Sep 30, 2010 (Started Jun 10, 2001)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 2 x 300 mg-150 mg-300 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: fatigue
  • 0 helpful marks
Last updated:
Showing 3 of 5 patient evaluations for Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)